Stuart N. L. Bennett

Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from a Drug Acyl Glucuronide Metabolite: Multiple Albumin Adductions in Diclofenac Patients

Thomas Hammond, Xiaoli Meng, Rosalind E. Jenkins et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 55 citations · Full text

Pharmacy, Biochemistry, Pharmacology +15

Free-Wilson and Structural Approaches to Co-optimizing Human and Rodent Isoform Potency for 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitors

Frederick W. Goldberg, Andrew G. Leach, James S. Scott et al. · Journal of Medicinal Chemistry · 2012 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Novel thienopyrrole glycogen phosphorylase inhibitors: Synthesis, in vitro SAR and crystallographic studies

Paul R. O. Whittamore, Matthew S. Addie, Stuart N. L. Bennett et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 29 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +7

New syntheses of arylphosphinic acids from the reaction of ethyl diethoxymethylphosphinate with aryl bromides and phenols

Stuart N. L. Bennett, Roger G. Hall · Journal of the Chemical Society Perkin Transactions 1 · 1995 · 24 citations

Natural Sciences, Chemistry, Catalysis +7

Reduction of acyl glucuronidation in a series of acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors: the discovery of AZD6925

James S. Scott, Peter Barton, Stuart N. L. Bennett et al. · MedChemComm · 2012 · 11 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14